150 related articles for article (PubMed ID: 984781)
1. Antimicrobiol susceptibility of Propinibacterium acnes and related microbial species.
Hoeffler U; Ko HL; Pulverer G
Antimicrob Agents Chemother; 1976 Sep; 10(3):387-94. PubMed ID: 984781
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial susceptibilities of Corynebacterium species and other non-spore-forming gram-positive bacilli to 18 antimicrobial agents.
Soriano F; Zapardiel J; Nieto E
Antimicrob Agents Chemother; 1995 Jan; 39(1):208-14. PubMed ID: 7695308
[TBL] [Abstract][Full Text] [Related]
3. Comparative activity of the topical quinolone OPC-7251 against bacteria associated with acne vulgaris.
Vogt K; Hermann J; Blume U; Gollnick H; Hahn H; Haustein UF; Orfanos CE
Eur J Clin Microbiol Infect Dis; 1992 Oct; 11(10):943-5. PubMed ID: 1486893
[TBL] [Abstract][Full Text] [Related]
4. Resistance of propionibacteria to antibiotics used in the treatment of acne.
Brown JM; Poston SM
J Med Microbiol; 1983 Aug; 16(3):271-80. PubMed ID: 6224016
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial susceptibility of Propionibacterium acnes isolated from acne vulgaris.
Kurokawa I; Nishijima S; Kawabata S
Eur J Dermatol; 1999; 9(1):25-8. PubMed ID: 9920982
[TBL] [Abstract][Full Text] [Related]
6. Effects of subminimal inhibitory concentrations of erythromycin, tetracycline, clindamycin, and minocycline on the neutrophil chemotactic factor production in Propionibacterium acnes biotypes 1-5.
Akamatsu H; Nishijima S; Takahashi M; Ushijima T; Asada Y
J Dermatol; 1991 May; 18(5):247-51. PubMed ID: 1834712
[TBL] [Abstract][Full Text] [Related]
7. Antibiotic susceptibility of Propionibacterium acnes isolated from orthopaedic implant-associated infections.
Khassebaf J; Hellmark B; Davidsson S; Unemo M; Nilsdotter-Augustinsson Å; Söderquist B
Anaerobe; 2015 Apr; 32():57-62. PubMed ID: 25541476
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial susceptibility of Propionibacterium acnes isolates from shoulder surgery.
Crane JK; Hohman DW; Nodzo SR; Duquin TR
Antimicrob Agents Chemother; 2013 Jul; 57(7):3424-6. PubMed ID: 23629711
[TBL] [Abstract][Full Text] [Related]
9. The bacteriology of acne vulgaris and antimicrobial susceptibility of Propionibacterium acnes and Staphylococcus epidermidis isolated from acne lesions.
Nishijima S; Kurokawa I; Katoh N; Watanabe K
J Dermatol; 2000 May; 27(5):318-23. PubMed ID: 10875198
[TBL] [Abstract][Full Text] [Related]
10. Differential susceptibility of Propionibacterium acnes, P. granulosum and P. avidum to free fatty acids.
Ko HL; Heczko PB; Pulverer G
J Invest Dermatol; 1978 Dec; 71(6):363-5. PubMed ID: 722112
[TBL] [Abstract][Full Text] [Related]
11. The antibiotic susceptibility of Propionibacterium acnes and Staphylococcus epidermidis isolated from acne.
Nishijima S; Akamatsu H; Akamatsu M; Kurokawa I; Asada Y
J Dermatol; 1994 Mar; 21(3):166-71. PubMed ID: 8014270
[TBL] [Abstract][Full Text] [Related]
12. Propionicins, bacteriocins produced by Propionibacterium avidum.
Ko HL; Pulverer G; Jeljaszewicz J
Zentralbl Bakteriol Orig A; 1978 Sep; 241(3):325-8. PubMed ID: 726736
[TBL] [Abstract][Full Text] [Related]
13. Suppression of polymorphonuclear leukocyte chemotactic factor production in Propionibacterium acnes by subminimal inhibitory concentrations of tetracycline, ampicillin, minocycline, and erythromycin.
Webster GF; Leyden JJ; McGinley KJ; McArthur WP
Antimicrob Agents Chemother; 1982 May; 21(5):770-2. PubMed ID: 7049078
[TBL] [Abstract][Full Text] [Related]
14. MLST typing of antimicrobial-resistant Propionibacterium acnes isolates from patients with moderate to severe acne vulgaris.
Giannopoulos L; Papaparaskevas J; Refene E; Daikos G; Stavrianeas N; Tsakris A
Anaerobe; 2015 Feb; 31():50-4. PubMed ID: 25451716
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of lipase activity in antibiotic-resistant propionibacterium acnes strains.
Gloor M; Wasik B; Becker A; Höffler U
Dermatology; 2002; 205(3):260-4. PubMed ID: 12399674
[TBL] [Abstract][Full Text] [Related]
16. European surveillance study on the antibiotic susceptibility of Propionibacterium acnes.
Oprica C; Nord CE;
Clin Microbiol Infect; 2005 Mar; 11(3):204-13. PubMed ID: 15715718
[TBL] [Abstract][Full Text] [Related]
17. Sensitivity of Propionibacterium acnes isolated from acne patients: comparative study of antimicrobial agents.
Nishijima S; Kurokawa I; Kawabata S
J Int Med Res; 1996; 24(6):473-7. PubMed ID: 8959531
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial susceptibility and genetic characteristics of Propionibacterium acnes isolated from patients with acne.
Schafer F; Fich F; Lam M; Gárate C; Wozniak A; Garcia P
Int J Dermatol; 2013 Apr; 52(4):418-25. PubMed ID: 23432195
[TBL] [Abstract][Full Text] [Related]
19. Phenotypic and genotypic characterization of antibiotic-resistant Propionibacterium acnes isolated from acne patients attending dermatology clinics in Europe, the U.S.A., Japan and Australia.
Ross JI; Snelling AM; Eady EA; Cove JH; Cunliffe WJ; Leyden JJ; Collignon P; Dréno B; Reynaud A; Fluhr J; Oshima S
Br J Dermatol; 2001 Feb; 144(2):339-46. PubMed ID: 11251569
[TBL] [Abstract][Full Text] [Related]
20. Comparative in vitro activities of retapamulin (SB-275833) against 141 clinical isolates of Propionibacterium spp., including 117 P. acnes isolates.
Goldstein EJ; Citron DM; Merriam CV; Warren YA; Tyrrell KL; Fernandez HT
Antimicrob Agents Chemother; 2006 Jan; 50(1):379-81. PubMed ID: 16377717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
